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Abstract
A 58-year-old male with a one-year history of lower medial eyelid swelling and no
other ocular and systemic abnormalities was examined. The examination revealed
a medial bluish firm left lower eyelid mass. Subsequently, he had an in toto
excisional biopsy of a cystic mass, which was confirmed histopathologically to be
syringocystadenoma papilliferum. A higher level of suspicion by the ophthalmologist
and the histopathologist plays a vital role in the management of this tumour.
1. Introduction
Syringocystadenoma papilliferum (SP) of the eyelid is a rare benign tumour of the
Moll’s glands equivalent to the sweat gland first reported in 1917 by John Stokes [1].
The tumour is not so common in the eyelid, and is often misdiagnosed as Cyst, BCC, or
SCC [2]. Hence, histopathology evaluation is needed to confirm the diagnosis.
Syringocystadenoma papilliferum is mostly a childhood tumour [3] with 50%
reported at birth and 15–35% presented at puberty [4]. However, it has been known to
be associated with other benign tumours such as viral warts, nevus sebaceous, linear
nevus verrucous, nevus comedonicus, apocrine poroma, apocrine hidrocystoma, tubu-
lopapillary hidradenoma, hidradenoma papilliferum and papillary eccrine adenoma [5].
Syringocystadenoma papilliferum can rarely transform into BCC, as has been reported
[4].
A thorough review of the literature in Google Scholar, African Journals Online (AJOL)
and Medline/PubMed yielded 17 cases of SP of the eyelid. We hereby report another
interesting case of SP of the eyelid.
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Figure 1: Microscopy section shows projected papillary, plasmacytic infiltrates and non-keratinised
epithelium.
2. A Case Report
A 58-year-old male with a non-progressing right lower eyelid swelling of one-year
duration, unassociated with pain, bleeding, itching and eye lashes loss was examined.
There is no preceding history of trauma and weight loss. Visual acuity (VA) in both
eyes was 6/6.
Physical examination revealed medial bluish firm Right Eye (RE) swelling measured
1.2cm x 0.6cm. Other ocular findings were normal in Both Eye (BE). There is no signif-
icant peripheral lymphadenopathy. The mass was excised in toto, and the wound was
closed primarily.
3. Histopathological Report
Gross examination showed a round to oval mass 10mm x 5mmm.
Microscopic examination of tissue sections shows an acanthotic non-keratinised
squamous epithelium overlying a cystic lesion composed of intra-cystic papillary struc-
tures lined by double layer of inner columnar and outer cuboidal cells (Figure 1) with
decapitation secretion seen within the luminal spaces. The fibrovascular cores show
plasmacytic infiltrations with decapitation secretion within the luminal spaces.
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4. Discussion
Syringocystadenoma papilliferum is a rare hamartoma benign tumour of the eyelid
first reported [1] in 1917, believed to arise from sweat gland and mostly seen in head
and neck region [1]. However, the occurrence of the tumour in other part of the
body have been reported. From looking into the literature through Google Scholar,
Medline/PubMed and African Journals Online (AJOL), 17 cases of eyelid SP have been
reported as of today. The highest numberwas by Barbarino et al. in 2009, who reported
14 number of cases, with age ranging 8–82years [6]. Our case was a 58-year old
similar to the age reported by Behera & Chatterjee [2]; however, older than the age
reported by Rao et al. [3] and Jakobiec et al. [7] . A clinical differential diagnosis of
this lid mass in our patient includes nevus sebaceous, hidradenoma, dermoid cyst,
BCC, SCC and keratoacanthoma. However, BCC and SCC are unlikely because of the
age of our patient. Keratoacanthoma is a rapid-growth tumour, however, the non-
rapid growth nature and age in our patient was not in favour of Keratoacanthoma.
The histopathological diagnosis of SP by Jakobiec et al. [7] were all seen in our
patient (cystic spaces within dermal, the dermis lined by non-keratinised epithelium,
papillary projection and prominent plasmacystic infiltration). There are still arguments
pertaining to the origin of SP: while some authors believe its apocrine origin, others
call it eccrine gland origin [8]. In our patient, apart from the eyelid swelling no other
ocular symptoms were noticed; however, there were previous reports of association
of pruritic [9], verrucous and hyperkeratotic surface lesion [6] with SP. Syringocys-
tadenoma papilliferum is known to be associated with many other benign tumours
such as apocrine cystadenoma [6], condyloma acuminatum [10], trichilemmoma
[11], hidradenoma [12], trichoblastoma [13], verrucous cyst [14] and tubular apocrine
adenoma [15], while our patient was associated with apocrine hydrocytoma.
The malignant transition into BCC [2], ductal carcinoma and metastatic adenocarci-
noma [16] have been reported in SP of other part of the body but none in the eyelid.
Themain treatment of SP of eyelid is excisional biopsy that was done in our case; how-
ever, carbon dioxide laser [17] and Mohs micrographic surgery [18] have been used
successfully in the treatment of SP. Two cases of recurrences of eyelid SP following
surgical excisional have been reported in the literature [19].
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5. Conclusion
Syringocystadenoma papilliferum of eyelid still remains a rare benign tumour that can
be easily misdiagnosed as cyst, BCC and SCC; hence higher index of suspicion by all
practising ophthalmologist and histopathologist plays an important role in its diagnosis.
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